Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19.

Damle, Bharat; Vourvahis, Manoli; Wang, Erjian; Leaney, Joanne; Corrigan, Brian

Damle, Bharat; Vourvahis, Manoli; Wang, Erjian; Leaney, Joanne; Corrigan, Brian.

Affiliation

Damle B; Pfizer Global Research and Development, New York, New York, USA.
Vourvahis M; Pfizer Global Research and Development, New York, New York, USA.
Wang E; Pfizer Global Research and Development, San Diego, California, USA.
Leaney J; Pfizer Global Research and Development, Sandwich, Kent, UK.
Corrigan B; Pfizer Global Research and Development, Groton, Connecticut, USA.

Clin Pharmacol Ther ; 108(2): 201-211, 2020 08.

Article in En | MEDLINE | ID: mdl-32302411

Subject(s)

Antiviral Agents/pharmacology; Azithromycin/pharmacology; Azithromycin/therapeutic use; Betacoronavirus/drug effects; Antiviral Agents/therapeutic use; Azithromycin/adverse effects; Azithromycin/pharmacokinetics; Betacoronavirus/pathogenicity; Clinical Trials as Topic; Coronavirus Infections/drug therapy; Drug Therapy, Combination; Humans; Hydroxychloroquine/pharmacology; Lung/drug effects; Microbial Sensitivity Tests; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Azithromycin / Betacoronavirus Type of study: Clinical_trials Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google